IP Library › Granted Patent US 7,718,173
Granted Patent B2
US 7,718,173 · App. 10/142,885 · Granted May 18, 2010

Anti-pro6094 antibodies

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,718,173
App. No.
10/142,885
Granted
May 18, 2010
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (1)

1. An isolated antibody that specifically binds to the extracellular domain of the polypeptide of SEQ ID NO:200, which is a humanized antibody.